MEDITE Cancer Diagnostics

The incidence of cancer is expecting to rise a further 57 % in the next two decades. The Company is emerging as rapidly growing disruptive force in the multi-billion dollar global histology and cytology systems marketplace while positioned to build significant shareholder value.

MEDITE’s Mission

MEDITE® Group is a medical technology company specializing in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. MEDITE is poised to become a disruptive force from rapid revenue and market share growth resulting from the introduction of major innovative products in the multibillion dollar global histology and cytology cancer detection marketplace. Depending upon the type of cancer, segments within the current target market of approximately $5.8 billion are growing at annual rates of 10% to 30%. MEDITE anticipates significant growth in revenue and earnings over the next years from several growth trajectories.

MEDITE Office Locations

Corporate Headquarters

4203 SW 34th Street
Orlando, FL 32811, U.S.A.
Phone: +1 407 996 9630
Fax: +1 407 996 9631
Toll Free No: 888 225 2950

Research & Development

888 E. Belvidere Rd. #306
Grayslake, IL 60030
Phone: +1 847 752-8690
Fax: +1 407 996 9631
Toll Free No: 888 225 2950

MEDITE Germany (GmbH)

Wollenweberstrasse 12
31303 Burgdorf
Phone: +49 5136 8884-0
Fax: +49 5136 8884-55

Stephen Von Rump, CEO

Stephen Von Rump


Stephen Von Rump joined Medite as the Chief Commercialization and Strategy Officer as well as the Managing Director of MEDITE GmbH in Germany in May 2017, and was appointed CEO in November 2017.  He has over 20 years of broad operational experience including R&D for software, electronic and mechanical development, manufacturing, technical service, project and quality management, intellectual property, regulatory activities, sales and marketing, and finance.  Mr. Von Rump has 8 years of experience in medical device technology and telehealth platforms, specifically focused on the remote care of elderly and others living with chronic conditions.  He has extensive international experience, leading and working with companies in Europe, Asia and North America.

Mr. Von Rump has founded/cofounded several companies including Giraff Technologies in Sweden, which developed the world’s first comprehensive remote care platform to include fully mobile telepresence; and BeHere Corporation in the U.S., a 360o videoconferencing and collaboration platform.  He was formerly the CEO of VTEL, then the second largest videoconferencing provider in the world and included a global telemedicine practice.

Mr. Von Rump is a designated “expert” with the European Commission in the health technology sector, evaluating R&D funding proposals for the Horizon 2020 Programme.  He is a veteran of four multi-national grant projects in the EU, and through these projects has twice won the AAL Forum’s annual Innovation Award.  He holds an M.S. Electrical Engineering degree from Washington University in the U.S.

Gary Pickett, Chief Financial Officer

Gary Pickett

Chief Financial Officer

Gary D. Pickett, CPA holds an MBA from the University of Tampa, a BS degree in Accounting from Florida State University, and served four years as a field artillery officer in the United States Army. Mr. Pickett has over 38 year’s of management experience including 11 years as a Chief Financial Officer (CFO). He served for three years as the CFO for Apex Executive Jet Center, a privately held full charter services company and eight years as CFO of Bovie Medical Corporation, a microcap publicly-traded medical manufacturing company. In addition prior to Bovie, Mr. Pickett held positions of Director of Financial Systems with Progress Energy Services of Raleigh, NC, Vice President and Controller of Progress Rail Services, a subsidiary of Progress Energy Services in Albertville, AL. He has had extensive experience in Sarbanes-Oxley implementation as well as GAAP accounting and SEC Reporting.

Jeff Rencher, Chief Marketing and Business Development Officer

Jeff Rencher

Chief Marketing and Business Development Officer

Jeff Rencher, joined  the company in May 2017 as the Chief Marketing and Business Development Officer and has worked in the medical device industry for twenty-four years.  He began as a surgical device representative in 1993 and in 2000, joined Gyrus Medical-ACMI (Currently Olympus Surgical) as a direct representative and subsequently promoted to Regional Director the following year.  In 2004, he was recruited by the CEO and Board of Directors of Inlet Medical/Carter Thomason, in Minneapolis, MN as Vice President of Sales.  Following the acquisition of Inlet Medical by Cooper Surgical, Mr. Rencher was tasked to head the sales and marketing efforts of Opticom Medical which was acquired in 2010.  He joined Bovie Medical in 2010 as Vice President of Sales and Marketing for Surgical Products.  Throughout his career he has been tasked to build national and international sales forces, create marketing material, coordinate medical studies with leading physicians and generate new sales through the sales channels he has developed over his multiple years in the industry.  He has extensive national and international relationships with physicians, hospital administration, and medical industry associates.  Mr. Rencher holds a BS in Biology from Tulane University and has a certificate in Medical Industry Management from St. Thomas University in Minneapolis.  He also holds an Emergency Medical Technician Certificate and is named on four U.S. issued patents.

Michael Kenealy, U.S. Director of Sales

Michael Kenealy

U.S. Director of Sales

Michael Kenealy, came to Medite in January 2016.  Mr. Kenealy has over 22 years of experience in sales management, customer development, and team leadership. Mike brings a wealth of experience in direct and distributor sales management which include several new product launches with companies like Kimberly-Clark and MERCK. Working with Merck, Mr. Kenealy brings a strong background in the sciences, working as a dual certified cardiovascular and diabetes specialist. As the NE Regional Laboratory Product Manager with Kimberly-Clark, Mr. Kenealy worked with large distribution, helping to developing new product categories and increased sales in Hospitals, Laboratories and Government Facilities in the NE, U.S. Mr. Kenealy brings extensive experience within a range of health care segments including specialty offices, hospitals, military facilities, VA hospitals, labs and clinics.  Mr. Kenealy has implemented a strategic approach to market analytics and applies data, utilizing market trends, scientific research, and account intelligence to expand our territories. Mr. Kenealy holds a BS degree from Central Michigan University. Mr. Kenealy has extended medical education certifications in; Medical Device Reporting, Operating Room Protocols, HIPAA, National Safety Patient Goals and Blood Pathogens.